A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.
Market Scope
Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis
Latest Reports Latest News
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Physician Surveys
For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.
Complete a Survey
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark Your Performance
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
View Market Insights & Analytics
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register Today
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 118
Comprehensive Pages
- 8
Geographic and Economic Breakouts
- 5
Year Market Forecasts
- 21
Company Profiles
Latest Industry News & Trends
4/3/2020
BreakingCOVID 19DiagnosticMeetingOphthalmicSurgical
COVID-19 Update: Abbott's New Rapid Test; WOC Goes Online-Only; EyePoint Cuts Workforce
Abbott Laboratories announced March 27 the launch of its diagnostic test for COVID-19 that can tell if someone is infected in as little as five minutes. The test has US FDA emergency use authorizat...
4/3/2020
BreakingDeviceLow VisionOphthalmicRetina
Second Sight to Wind Down Operations due to Impact of COVID-19 Pandemic
.png)
Second Sight Medical Products announced March 30 in an SEC filing that it would lay off 84 of its 108 employees permanently as it winds down operations and closes its facility. The Sylmar, Californ...
4/3/2020
BreakingDeviceGlaucomaOphthalmicRegulation
China Approves Use of Allergan’s XEN Gel Stent for Refractory Glaucoma
China’s National Medical Products Administration (NMPA) has approved the XEN Gel stent for the surgical management of patients with refractory glaucoma, Allergan announced April 2. It was the first...
4/3/2020
BreakingOphthalmicPharmaRegulation
Eyevance Launches Zerviate in the US for Allergic Conjunctivitis
Eyevance Pharmaceuticals announced March 30 the US launch of Zerviate (cetirizine ophthalmic solution) 0.24% for the treatment of ocular itching associated with allergic conjunctivitis. The Fort Wo...
3/27/2020
BreakingCOVID 19MeetingOphthalmic
Market Scope Lists 2020 Ophthalmic Meetings Canceled, Delayed Due to COVID-19
.jpg)
Market Scope is tracking the status of 2020 ophthalmic meetings worldwide as the COVID-19 outbreak spreads. Several conferences have been delayed or canceled outright. Here is the latest informatio...
4/3/2020
BreakingClinical TrialOphthalmicPharma
Immunovant’s Anti-FcRn Antibody Shows Positive Results for Thyroid Eye Disease
Immunovant, of New York, announced March 30 that it had seen positive results in its ongoing Phase IIa study of IMVT-1401 in patients with thyroid eye disease (TED), also known as Graves’ ophthalmo...
4/3/2020
BreakingDeviceLow VisionOphthalmicRetina
Nano Retina’s NR600 Retinal Prosthesis Implanted in First Two Patients
Nano Retina, of Israel, announced March 30 that its NR600 retinal prosthesis had been implanted in two patients blinded by retinitis pigmentosa, and the device produced visual effects. Retina speci...
4/3/2020
BreakingDealsDiagnosticOphthalmicSurgical
MST Acquires IRISS Medical Technologies and its Volk Eye Check
MicroSurgical Technology (MST) reported March 26 that it had acquired UK-based IRISS Medical Technologies Limited. Details were not disclosed. IRISS’ main technology is the Volk Eye Check, a hand-h...
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.